There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with se ...

A recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations ...

The rise is attributed to population growth and low asthma-related mortality. The 12-month diagnosed prevalent cases of ...

Warning signs of asthma include frequent coughing, wheezing, shortness of breath, chest tightness, and increased fatigue.

There may be a more effective treatment for severe asthma and chronic obstructive pulmonary disease (COPD) attacks than that used as the standard of care for 50 years, according to a recent study.

Some treatments show potential for wider application. Biologic therapies are helping advance severe asthma management by ...

The main reason for the expected increase in the 12-month and lifetime diagnosed prevalent cases of severe asthma is ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

“Benralizumab is a safe and effective drug already used to manage severe asthma. We’ve used the drug in a different way -- at the point of an exacerbation -- to show that it’s more effective ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug. The final appraisal ...

If you have asthma, influenza can lead to severe complications, including exacerbations that may require you to be ...